We are live on ! Find out more
ABEO icon

Abeona Therapeutics
ABEO

104 hedge funds and large institutions have $444M invested in Abeona Therapeutics in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 34 increasing their positions, 24 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

163% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 8

42% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 24

13% more funds holding

Funds holding: 92 → 104 (+12)

8% more call options, than puts

Call options by funds: $2.64M | Put options by funds: $2.44M

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.19% less ownership

Funds ownership: 3.09% → 2.9% (-0.19%)

24% less capital invested

Capital invested by funds: $585M → $444M (-$140M)

Holders
104
Holders Change
+12
Holders Change %
+13.04%
% of All Funds
2.38%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
34
Reduced
24
Closed
8
Calls
$2.64M
Puts
$2.44M
Net Calls
+$200K
Net Calls Change
-$4.61M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$11M
2
Marshall Wace
Marshall Wace
United Kingdom
+$4.24M
3
NC
Nexthera Capital
New York
+$3.17M
4
PA
Perceptive Advisors
New York
+$2.57M
5
SFM
Sphera Funds Management
Israel
+$1.61M

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$25.2M
2
State Street
State Street
Massachusetts
-$12.5M
3
PC
PointState Capital
New York
-$9.21M
4
Millennium Management
Millennium Management
New York
-$4.09M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.36M -$1.68M -4,735 -53%
JP Morgan Chase
27
JP Morgan Chase
New York
$1.35M -$1.03M -2,898 -41%
TA
28
Teachers Advisors
New York
$1.26M +$600K +1,691 +76%
RJFSA
29
Raymond James Financial Services Advisors
Florida
$1.15M +$1.27M +3,580 New
TD Asset Management
30
TD Asset Management
Ontario, Canada
$1.08M +$42.6K +120 +4%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$933K +$1.03M +2,917 New
Creative Planning
32
Creative Planning
Kansas
$875K +$970K +2,735 New
Charles Schwab
33
Charles Schwab
California
$864K +$65.3K +184 +7%
CT
34
Cambridge Trust
Massachusetts
$837K – – –
AS
35
Altshuler Shaham
Israel
$815K – – –
Alkeon Capital Management
36
Alkeon Capital Management
New York
$787K – – –
TCIM
37
TIAA CREF Investment Management
New York
$770K -$76.3K -215 -8%
BGIM
38
Brandywine Global Investment Management
Pennsylvania
$736K +$1.42K +4 +0.2%
Goldman Sachs
39
Goldman Sachs
New York
$692K +$536K +1,512 +233%
Swiss National Bank
40
Swiss National Bank
Switzerland
$641K – – –
Wells Fargo
41
Wells Fargo
California
$637K +$21.3K +60 +3%
AllianceBernstein
42
AllianceBernstein
Tennessee
$618K – – –
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$608K +$4.61K +13 +0.7%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$589K -$135K -380 -17%
Balyasny Asset Management
45
Balyasny Asset Management
Illinois
$515K +$252K +709 +79%
Citadel Advisors
46
Citadel Advisors
Florida
$511K +$91.2K +257 +19%
Jane Street
47
Jane Street
New York
$493K +$547K +1,541 New
AAP
48
Ardsley Advisory Partners
Connecticut
$448K +$142K +400 +40%
UBS Group
49
UBS Group
Switzerland
$427K +$452K +1,275 +2,125%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$422K – – –
1
2
3 4 5

ABEO Hedge Fund Activity: Q3 2018 in Review

104 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q3 2018, worth a combined $444M — down 24% from $585M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new ABEO positions and 8 closed out — a net gain of 13 holders — while 34 added to existing stakes and 24 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $11M. The largest seller was Viking Global Investors, cutting an estimated $25.2M.

  • 104 institutional investors held Abeona Therapeutics (ABEO) as of Q3 2018, up from 92 in Q2 2018.
  • Funds reported $444M of Abeona Therapeutics stock for Q3 2018, down 24% quarter-over-quarter.
  • 21 funds opened new Abeona Therapeutics positions in Q3 2018 and 8 closed out, a net change of +13 holders.
  • The largest Abeona Therapeutics buyer in Q3 2018 was Wellington Management Group, an estimated $11M added.
  • The largest Abeona Therapeutics seller in Q3 2018 was Viking Global Investors, an estimated $25.2M sold.

Based on aggregated 13F filings for Q3 2018.